Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Many patients with advanced pancreatic cancer and colorectal cancer experience burdensome and difficult-to-treat symptoms. The impact of multiple symptoms (called "symptom burden") can negatively affect a patient's quality of life, decrease their ability to tolerate cancer treatments, and lead to worse survival. Current approaches to manage these cancer-associated symptoms often work poorly, with most patients reporting a moderate to severe symptom burden. Therefore, there is an urgent need for treatments that improve these symptoms in patients with advanced pancreatic and colorectal cancer, and data suggests that medical cannabis can help. In this research study, we are examining the usefulness of using medical cannabis in patients with advanced pancreatic cancer and colorectal cancer to further study how cannabis can impact their symptom burden.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzony rozpoznaniem raka trzustki lub jelita grubego w zaawansowanym stadium
- •Brak planów operacyjnego leczenia w ciągu najbliższych 3 miesięcy
- •Doświadczenie nudności, wymiotów, braku apetytu, osłabienia lub bólu w ciągu ostatnich 2 tygodni
- •Rozpoczęcie standardowej chemioterapii w ostatnich 2 tygodniach w uczestniczącym ośrodku
- •Zamieszkanie w stanie Minnesota
- •Chęć zarejestrowania się w Programie Medycznej Marihuany w stanie Minnesota
- •Gotowość do udzielania informacji o samopoczuciu na każdym etapie badania
✗ Disqualifies
- •Regularne stosowanie produktów zawierających THC (10 lub więcej dni w ostatnim miesiącu)
- •Historia alergii lub złej tolerancji marihuany
- •Choroba Alzheimera, aktywna epilepsja lub historia poważnego urazu głowy
- •Przerzuty nowotworu do mózgu aktualnie leczone lub nieleczone
- •Rozpoczęcie immunoterapii lub innych eksperymentalnych leków przeciwnowotworowych
- •Jednoczesne stosowanie chemioterapii i immunoterapii
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
HealthPartners Cancer Research Center
Saint Louis Park, United States
Trial contact
Alissa Gavenda, RN
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.